Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells

Sougat Misra, Arun Kumar Selvam, Marita Wallenberg, Aditya Ambati, A. Matolcsy, Isabelle Magalhaes, Gilbert Lauter, Mikael Björnstedt

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Selective targeting of the PML/RARa oncoprotein demonstrates a successful molecular targeted therapy in acute promyelocytic leukemia (APL) with a typical t(15:17) chromosomal translocation. The zinc-thiolate coordination is critical for structural stability of zinc finger proteins, including the PML moiety of PML/RARa. Based on the known interaction of redox-active selenium compounds with thiolate ligands of zinc, we herein have investigated the abrogatory effects of selenite alone or in combination with all-trans retinoic acid on PML/RARa and the possible effects on differentiation in these cells. At pharmacological concentrations, selenite inhibited the proliferation and survival of APL originated NB4 cells. In combination with ATRA, it potentiated the differentiation of NB4 cells without any differentiating effects of its own as a single agent. Concordant with our hypothesis, PML/RARa oncoprotein expression was completely abrogated by selenite. Increased expression of RAR, PU.1 and FOXO3A transcription factors in the combined treatment suggested the plausible basis for increased differentiation in these cells. We show that selenite at clinically achievable dose targets PML/RARa oncoprotein for degradation and potentiates differentiation of promyelocytic leukemic cells in combination with ATRA. The present investigation reveals the hitherto unknown potential of selenite in targeted abrogation of PML/RARa in APL cells with prospective therapeutic value.

Original languageEnglish
Pages (from-to)74686-74700
Number of pages15
JournalOncotarget
Volume7
Issue number46
DOIs
Publication statusPublished - 2016

Fingerprint

Selenious Acid
Acute Promyelocytic Leukemia
Tretinoin
Oncogene Proteins
Cell Differentiation
Zinc
Selenium Compounds
Molecular Targeted Therapy
Genetic Translocation
Zinc Fingers
Oxidation-Reduction
Transcription Factors
Pharmacology
Ligands
Therapeutics
Proteins

Keywords

  • Acute myeloid leukemia
  • All-trans retinoic acid
  • Differentiation
  • PML/RARA
  • Selenite

ASJC Scopus subject areas

  • Oncology

Cite this

Misra, S., Selvam, A. K., Wallenberg, M., Ambati, A., Matolcsy, A., Magalhaes, I., ... Björnstedt, M. (2016). Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget, 7(46), 74686-74700. https://doi.org/10.18632/oncotarget.12531

Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. / Misra, Sougat; Selvam, Arun Kumar; Wallenberg, Marita; Ambati, Aditya; Matolcsy, A.; Magalhaes, Isabelle; Lauter, Gilbert; Björnstedt, Mikael.

In: Oncotarget, Vol. 7, No. 46, 2016, p. 74686-74700.

Research output: Contribution to journalArticle

Misra, S, Selvam, AK, Wallenberg, M, Ambati, A, Matolcsy, A, Magalhaes, I, Lauter, G & Björnstedt, M 2016, 'Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells', Oncotarget, vol. 7, no. 46, pp. 74686-74700. https://doi.org/10.18632/oncotarget.12531
Misra, Sougat ; Selvam, Arun Kumar ; Wallenberg, Marita ; Ambati, Aditya ; Matolcsy, A. ; Magalhaes, Isabelle ; Lauter, Gilbert ; Björnstedt, Mikael. / Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. In: Oncotarget. 2016 ; Vol. 7, No. 46. pp. 74686-74700.
@article{9446b086806142f6b52d5ab3278c2505,
title = "Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells",
abstract = "Selective targeting of the PML/RARa oncoprotein demonstrates a successful molecular targeted therapy in acute promyelocytic leukemia (APL) with a typical t(15:17) chromosomal translocation. The zinc-thiolate coordination is critical for structural stability of zinc finger proteins, including the PML moiety of PML/RARa. Based on the known interaction of redox-active selenium compounds with thiolate ligands of zinc, we herein have investigated the abrogatory effects of selenite alone or in combination with all-trans retinoic acid on PML/RARa and the possible effects on differentiation in these cells. At pharmacological concentrations, selenite inhibited the proliferation and survival of APL originated NB4 cells. In combination with ATRA, it potentiated the differentiation of NB4 cells without any differentiating effects of its own as a single agent. Concordant with our hypothesis, PML/RARa oncoprotein expression was completely abrogated by selenite. Increased expression of RAR, PU.1 and FOXO3A transcription factors in the combined treatment suggested the plausible basis for increased differentiation in these cells. We show that selenite at clinically achievable dose targets PML/RARa oncoprotein for degradation and potentiates differentiation of promyelocytic leukemic cells in combination with ATRA. The present investigation reveals the hitherto unknown potential of selenite in targeted abrogation of PML/RARa in APL cells with prospective therapeutic value.",
keywords = "Acute myeloid leukemia, All-trans retinoic acid, Differentiation, PML/RARA, Selenite",
author = "Sougat Misra and Selvam, {Arun Kumar} and Marita Wallenberg and Aditya Ambati and A. Matolcsy and Isabelle Magalhaes and Gilbert Lauter and Mikael Bj{\"o}rnstedt",
year = "2016",
doi = "10.18632/oncotarget.12531",
language = "English",
volume = "7",
pages = "74686--74700",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "46",

}

TY - JOUR

T1 - Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells

AU - Misra, Sougat

AU - Selvam, Arun Kumar

AU - Wallenberg, Marita

AU - Ambati, Aditya

AU - Matolcsy, A.

AU - Magalhaes, Isabelle

AU - Lauter, Gilbert

AU - Björnstedt, Mikael

PY - 2016

Y1 - 2016

N2 - Selective targeting of the PML/RARa oncoprotein demonstrates a successful molecular targeted therapy in acute promyelocytic leukemia (APL) with a typical t(15:17) chromosomal translocation. The zinc-thiolate coordination is critical for structural stability of zinc finger proteins, including the PML moiety of PML/RARa. Based on the known interaction of redox-active selenium compounds with thiolate ligands of zinc, we herein have investigated the abrogatory effects of selenite alone or in combination with all-trans retinoic acid on PML/RARa and the possible effects on differentiation in these cells. At pharmacological concentrations, selenite inhibited the proliferation and survival of APL originated NB4 cells. In combination with ATRA, it potentiated the differentiation of NB4 cells without any differentiating effects of its own as a single agent. Concordant with our hypothesis, PML/RARa oncoprotein expression was completely abrogated by selenite. Increased expression of RAR, PU.1 and FOXO3A transcription factors in the combined treatment suggested the plausible basis for increased differentiation in these cells. We show that selenite at clinically achievable dose targets PML/RARa oncoprotein for degradation and potentiates differentiation of promyelocytic leukemic cells in combination with ATRA. The present investigation reveals the hitherto unknown potential of selenite in targeted abrogation of PML/RARa in APL cells with prospective therapeutic value.

AB - Selective targeting of the PML/RARa oncoprotein demonstrates a successful molecular targeted therapy in acute promyelocytic leukemia (APL) with a typical t(15:17) chromosomal translocation. The zinc-thiolate coordination is critical for structural stability of zinc finger proteins, including the PML moiety of PML/RARa. Based on the known interaction of redox-active selenium compounds with thiolate ligands of zinc, we herein have investigated the abrogatory effects of selenite alone or in combination with all-trans retinoic acid on PML/RARa and the possible effects on differentiation in these cells. At pharmacological concentrations, selenite inhibited the proliferation and survival of APL originated NB4 cells. In combination with ATRA, it potentiated the differentiation of NB4 cells without any differentiating effects of its own as a single agent. Concordant with our hypothesis, PML/RARa oncoprotein expression was completely abrogated by selenite. Increased expression of RAR, PU.1 and FOXO3A transcription factors in the combined treatment suggested the plausible basis for increased differentiation in these cells. We show that selenite at clinically achievable dose targets PML/RARa oncoprotein for degradation and potentiates differentiation of promyelocytic leukemic cells in combination with ATRA. The present investigation reveals the hitherto unknown potential of selenite in targeted abrogation of PML/RARa in APL cells with prospective therapeutic value.

KW - Acute myeloid leukemia

KW - All-trans retinoic acid

KW - Differentiation

KW - PML/RARA

KW - Selenite

UR - http://www.scopus.com/inward/record.url?scp=84996644235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996644235&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.12531

DO - 10.18632/oncotarget.12531

M3 - Article

VL - 7

SP - 74686

EP - 74700

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 46

ER -